VANGUARD GROUP INC

Holdings History for ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)

Symbol: ALNY on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 13.1M shares
Security Ownership: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in ALNYLAM PHARMACEUTICALS, INC. Common Stock (ALNY)

2025-04-07 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13.1M shares of ALNYLAM PHARMACEUTICALS, INC. Common Stock (ALNY). This represents 10% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	10.03%		$3.53B	13.1M			$270.02	13G/A	3/31/2025	7 Apr 2025 11:51:33

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.05%	+0%	$3B	12.7M	+98,303	+0.78%	$235.31	Q4 2024
9/30/2024	0.06%	+0%	$3.48B	12.6M	+127,318	+1.02%	$275.03	Q3 2024
6/30/2024	0.06%	+0%	$3.04B	12.5M	+513,517	+4.28%	$243.00	Q2 2024
3/31/2024	0.04%	+0%	$1.79B	12M	+50,366	+0.42%	$149.45	Q1 2024
12/31/2023	0.05%	+0%	$2.29B	11.9M	+287,064	+2.46%	$191.41	Q4 2023
9/30/2023	0.05%	+0%	$2.06B	11.7M	+30,608	+0.26%	$177.10	Q3 2023
6/30/2023	0.05%	+0%	$2.21B	11.6M	+18,056	+0.16%	$189.94	Q2 2023
3/31/2023	0.06%	+0%	$2.33B	11.6M	+101,051	+0.88%	$200.32	Q1 2023
12/31/2022	0.07%	+0%	$2.73B	11.5M	+453,808	+4.11%	$237.65	Q4 2022
9/30/2022	0.07%	+0%	$2.21B	11.1M	+10,870	+0.1%	$200.16	Q3 2022
6/30/2022	0.05%	+0%	$1.61B	11M	+213,294	+1.97%	$145.85	Q2 2022
3/31/2022	0.04%	+0%	$1.77B	10.8M	+126,373	+1.18%	$163.29	Q1 2022
12/31/2021	0.04%	+0%	$1.81B	10.7M	+88,189	+0.83%	$169.58	Q4 2021
9/30/2021	0.05%	+0%	$2B	10.6M	+116,888	+1.11%	$188.81	Q3 2021
6/30/2021	0.04%	0%	$1.78B	10.5M	-88,127	-0.83%	$169.52	Q2 2021
3/31/2021	0.04%	+0%	$1.49B	10.6M	+59,397	+0.56%	$141.19	Q1 2021
12/31/2020	0.04%	0%	$1.37B	10.5M	-5,782	-0.05%	$129.97	Q4 2020
9/30/2020	0.05%	0%	$1.53B	10.5M	-368,978	-3.38%	$145.60	Q3 2020
6/30/2020	0.06%	+0%	$1.61B	10.9M	+355,379	+3.37%	$148.11	Q2 2020
3/31/2020	0.05%	+0%	$1.15B	10.5M	+258,333	+2.51%	$108.85	Q1 2020
12/31/2019	0.04%	+0%	$1.18B	10.3M	+124,601	+1.23%	$115.17	Q4 2019
9/30/2019	0.03%	+0%	$817M	10.2M	+846,185	+9.08%	$80.42	Q3 2019
6/30/2019	0.03%	+0%	$676M	9.32M	+657,595	+7.59%	$72.56	Q2 2019
3/31/2019	0.03%	+0%	$809M	8.66M	+439,757	+5.35%	$93.45	Q1 2019
12/31/2018	0.03%	+0%	$599M	8.22M	+614,081	+8.07%	$72.91	Q4 2018
9/30/2018	0.03%	+0%	$666M	7.61M	+66,740	+0.89%	$87.52	Q3 2018
6/30/2018	0.03%	+0%	$742M	7.54M	+95,107	+1.28%	$98.49	Q2 2018
3/31/2018	0.04%	+0%	$887M	7.44M	+179,492	+2.47%	$119.10	Q1 2018
12/31/2017	0.04%	+0%	$923M	7.26M	+771,016	+11.9%	$127.05	Q4 2017
9/30/2017	0.04%	+0%	$763M	6.49M	+73,390	+1.14%	$117.49	Q3 2017
6/30/2017	0.03%	+0%	$512M	6.42M	+759,295	+13.4%	$79.76	Q2 2017
3/31/2017	0.01%	+0%	$290M	5.66M	+200,890	+3.68%	$51.25	Q1 2017
12/31/2016	0.01%	+0%	$204M	5.46M	+41,374	+0.76%	$37.44	Q4 2016
9/30/2016	0.02%	+0%	$367M	5.42M	+32,440	+0.6%	$67.78	Q3 2016
6/30/2016	0.02%	+0%	$299M	5.39M	+182,614	+3.51%	$55.49	Q2 2016
3/31/2016	0.02%	+0%	$327M	5.2M	+154,674	+3.06%	$62.77	Q1 2016
12/31/2015	0.03%	+0%	$475M	5.05M	+416,709	+9%	$94.14	Q4 2015
9/30/2015	0.03%	+0%	$372M	4.63M	+91,515	+2.02%	$80.36	Q3 2015
6/30/2015	0.04%	+0%	$544M	4.54M	+212,011	+4.9%	$119.87	Q2 2015
3/31/2015	0.03%	+0%	$452M	4.33M	+607,212	+16.3%	$104.42	Q1 2015
12/31/2014	0.03%	+0%	$361M	3.72M	+137,474	+3.84%	$97.00	Q4 2014
9/30/2014	0.02%	+0%	$280M	3.58M	+306,374	+9.35%	$78.10	Q3 2014
6/30/2014	0.02%	+0%	$207M	3.28M	+595,350	+22.2%	$63.17	Q2 2014
3/31/2014	0.02%	0%	$180M	2.68M	-285,677	-9.63%	$67.14	Q1 2014
12/31/2013	0.02%		$191M	2.97M			$64.33	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.